IndexIQ Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$420K Sell
1,854
-12
-0.6% -$2.82K 0.01% 455
2021
Q4
$504K Sell
1,866
-98
-5% -$24.3K 0.02% 560
2021
Q3
$475K Buy
1,964
+96
+5% +$24.2K 0.02% 602
2021
Q2
$443K Buy
1,868
+59
+3% +$13.4K 0.02% 561
2021
Q1
$396K Buy
1,809
+228
+14% +$45.8K 0.01% 824
2020
Q4
$276K Buy
1,581
+741
+88% +$128K 0.01% 736
2020
Q3
$136K Buy
840
+506
+151% +$80.2K 0.01% 876
2020
Q2
$48K Buy
334
+294
+735% +$40.7K ﹤0.01% 929
2020
Q1
$4K Sell
40
-1
-2% -$144 ﹤0.01% 911
2019
Q4
$6K Buy
+41
New +$5.92K ﹤0.01% 709
2019
Q1
Sell
-50,465
Closed -$5.48M 641
2018
Q4
$5.48M Buy
50,465
+18,368
+57% +$2.46M 0.15% 118
2018
Q3
$4.79M Sell
32,097
-14,341
-31% -$2.18M 0.16% 100
2018
Q2
$7.16M Buy
46,438
+15,386
+50% +$2.32M 0.22% 76
2018
Q1
$4.32M Buy
+31,052
New +$4.56M 0.14% 150

Other funds holding LH

IndexIQ Advisors's LH Position: Q1 2022 in Review

IndexIQ Advisors reduced its Labcorp (LH) stake by 0.64% in Q1 2022, selling an estimated $2.82K and leaving 1,854 shares worth $420K. The position accounts for 0.01% of the portfolio, ranked #455.

IndexIQ Advisors first reported a position in LH in Q1 2018 and has held it in 14 quarters since. The position peaked at $7.16M in Q2 2018. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • IndexIQ Advisors held 1,854 shares of Labcorp worth $420K as of Q1 2022.
  • IndexIQ Advisors sold 12 Labcorp shares in Q1 2022, an estimated $2.82K.
  • Labcorp made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #455 holding.
  • IndexIQ Advisors first reported a position in Labcorp in Q1 2018 and has held it in 14 quarters since.
  • IndexIQ Advisors's Labcorp position peaked at $7.16M in Q2 2018.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.